Tokyo, Dec. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059982) titled 'Validation of optimal hormone levels in transgender women' on Dec. 4.
Study Type:
Observational
Primary Sponsor:
Institute - Sapporo Medical University
Condition:
Condition - transgender women
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To validate optimal testosterone and estradiol levels in transgender women
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male
Key inclusion criteria - Transgender women undergoing gender-affirming hormone therapy
Key exclusion criteria - Transgender women who...